Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?

Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by a genetic dysregulation of the alternative complement pathway, characterized by thrombocytopenia, hemolytic anemia, and acute kidney injury, and included in the group of thrombotic microangiopathies. With the introduction of human...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2023-10, Vol.24 (19), p.14496
Main Authors: Spasiano, Andrea, Palazzetti, Daniela, Dimartino, Lucrezia, Bruno, Francesca, Baccaro, Rocco, Pesce, Francesco, Grandaliano, Giuseppe
Format: Article
Language:English
Subjects:
Antibodies
Chromosomes
Genes
Glycoproteins
Hypertension
Immune system
Influenza
Kidneys
Kinases
Mutation
Pathogenesis
Proteins
Rare diseases
Review
Severe acute respiratory syndrome coronavirus 2
Streptococcus infections
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63
cites cdi_FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63
container_end_page
container_issue 19
container_start_page 14496
container_title International journal of molecular sciences
container_volume 24
creator Spasiano, Andrea
Palazzetti, Daniela
Dimartino, Lucrezia
Bruno, Francesca
Baccaro, Rocco
Pesce, Francesco
Grandaliano, Giuseppe
description Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by a genetic dysregulation of the alternative complement pathway, characterized by thrombocytopenia, hemolytic anemia, and acute kidney injury, and included in the group of thrombotic microangiopathies. With the introduction of humanized monoclonal antibodies that inhibit C5 activation, the natural history of aHUS completely changed, with a better prognosis, a quick recovery of renal function, and a significant reduction of end-stage renal disease incidence. Nowadays, there is an increasing interest in the molecular and genetic bases of this severe disease. The aim of this narrative review is to provide readers with a practical guide about different possible involved genes, elucidating the specific role of each transcribed protein in the pathogenesis of aHUS. Moreover, we analyzed the main current evidence about the relationship among genetic mutations, outcomes, and the risk of recurrence of this manifold disease.
doi_str_mv 10.3390/ijms241914496
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10572301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2876750436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63</originalsourceid><addsrcrecordid>eNpdkUtrHDEQhEVIiB_JMXdBLrmM3XrsaJSLCevYDhh8iJeQk5A0vV4tM5IjaRz232cWG2Pn1A39dVFFEfKJwYkQGk7DdixcMs2k1O0bcsgk5w1Aq96-2A_IUSlbAC74Qr8nB0J187OUh-T3KvaYh12Id_QSI9bgC01raq9WP7_SX5vgN3SZYkRfQ4r0b6gbejNVn0akNvb0NqOtI8ZKz0PxKdYQJ7tHzz6Qd2s7FPz4NI_J6uL77fKqub65_LH8dt14oUVtGHe945y3ymoPiJ67FmANnHWKO2e9cFZqx9FKp1XbM9C2B8uxd9BpbMUxOXvUvZ_ciL2fvWQ7mPscRpt3JtlgXl9i2Ji79GAYLBQXwGaFL08KOf2ZsFQzzllwGGzENBXDO6VEt-iUnNHP_6HbNOU459tTrVqAFHtLzSPlcyol4_rZDQOzb828ak38A26zioE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876750436</pqid></control><display><type>article</type><title>Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Spasiano, Andrea ; Palazzetti, Daniela ; Dimartino, Lucrezia ; Bruno, Francesca ; Baccaro, Rocco ; Pesce, Francesco ; Grandaliano, Giuseppe</creator><creatorcontrib>Spasiano, Andrea ; Palazzetti, Daniela ; Dimartino, Lucrezia ; Bruno, Francesca ; Baccaro, Rocco ; Pesce, Francesco ; Grandaliano, Giuseppe</creatorcontrib><description>Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by a genetic dysregulation of the alternative complement pathway, characterized by thrombocytopenia, hemolytic anemia, and acute kidney injury, and included in the group of thrombotic microangiopathies. With the introduction of humanized monoclonal antibodies that inhibit C5 activation, the natural history of aHUS completely changed, with a better prognosis, a quick recovery of renal function, and a significant reduction of end-stage renal disease incidence. Nowadays, there is an increasing interest in the molecular and genetic bases of this severe disease. The aim of this narrative review is to provide readers with a practical guide about different possible involved genes, elucidating the specific role of each transcribed protein in the pathogenesis of aHUS. Moreover, we analyzed the main current evidence about the relationship among genetic mutations, outcomes, and the risk of recurrence of this manifold disease.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms241914496</identifier><identifier>PMID: 37833944</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Antibodies ; Chromosomes ; Genes ; Glycoproteins ; Hypertension ; Immune system ; Influenza ; Kidneys ; Kinases ; Mutation ; Pathogenesis ; Proteins ; Rare diseases ; Review ; Severe acute respiratory syndrome coronavirus 2 ; Streptococcus infections ; Transplants &amp; implants</subject><ispartof>International journal of molecular sciences, 2023-10, Vol.24 (19), p.14496</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63</citedby><cites>FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63</cites><orcidid>0000-0002-6044-7256</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2876750436/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2876750436?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768,74155,74869</link.rule.ids></links><search><creatorcontrib>Spasiano, Andrea</creatorcontrib><creatorcontrib>Palazzetti, Daniela</creatorcontrib><creatorcontrib>Dimartino, Lucrezia</creatorcontrib><creatorcontrib>Bruno, Francesca</creatorcontrib><creatorcontrib>Baccaro, Rocco</creatorcontrib><creatorcontrib>Pesce, Francesco</creatorcontrib><creatorcontrib>Grandaliano, Giuseppe</creatorcontrib><title>Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?</title><title>International journal of molecular sciences</title><description>Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by a genetic dysregulation of the alternative complement pathway, characterized by thrombocytopenia, hemolytic anemia, and acute kidney injury, and included in the group of thrombotic microangiopathies. With the introduction of humanized monoclonal antibodies that inhibit C5 activation, the natural history of aHUS completely changed, with a better prognosis, a quick recovery of renal function, and a significant reduction of end-stage renal disease incidence. Nowadays, there is an increasing interest in the molecular and genetic bases of this severe disease. The aim of this narrative review is to provide readers with a practical guide about different possible involved genes, elucidating the specific role of each transcribed protein in the pathogenesis of aHUS. Moreover, we analyzed the main current evidence about the relationship among genetic mutations, outcomes, and the risk of recurrence of this manifold disease.</description><subject>Antibodies</subject><subject>Chromosomes</subject><subject>Genes</subject><subject>Glycoproteins</subject><subject>Hypertension</subject><subject>Immune system</subject><subject>Influenza</subject><subject>Kidneys</subject><subject>Kinases</subject><subject>Mutation</subject><subject>Pathogenesis</subject><subject>Proteins</subject><subject>Rare diseases</subject><subject>Review</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Streptococcus infections</subject><subject>Transplants &amp; implants</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNpdkUtrHDEQhEVIiB_JMXdBLrmM3XrsaJSLCevYDhh8iJeQk5A0vV4tM5IjaRz232cWG2Pn1A39dVFFEfKJwYkQGk7DdixcMs2k1O0bcsgk5w1Aq96-2A_IUSlbAC74Qr8nB0J187OUh-T3KvaYh12Id_QSI9bgC01raq9WP7_SX5vgN3SZYkRfQ4r0b6gbejNVn0akNvb0NqOtI8ZKz0PxKdYQJ7tHzz6Qd2s7FPz4NI_J6uL77fKqub65_LH8dt14oUVtGHe945y3ymoPiJ67FmANnHWKO2e9cFZqx9FKp1XbM9C2B8uxd9BpbMUxOXvUvZ_ciL2fvWQ7mPscRpt3JtlgXl9i2Ji79GAYLBQXwGaFL08KOf2ZsFQzzllwGGzENBXDO6VEt-iUnNHP_6HbNOU459tTrVqAFHtLzSPlcyol4_rZDQOzb828ak38A26zioE</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Spasiano, Andrea</creator><creator>Palazzetti, Daniela</creator><creator>Dimartino, Lucrezia</creator><creator>Bruno, Francesca</creator><creator>Baccaro, Rocco</creator><creator>Pesce, Francesco</creator><creator>Grandaliano, Giuseppe</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6044-7256</orcidid></search><sort><creationdate>20231001</creationdate><title>Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?</title><author>Spasiano, Andrea ; Palazzetti, Daniela ; Dimartino, Lucrezia ; Bruno, Francesca ; Baccaro, Rocco ; Pesce, Francesco ; Grandaliano, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antibodies</topic><topic>Chromosomes</topic><topic>Genes</topic><topic>Glycoproteins</topic><topic>Hypertension</topic><topic>Immune system</topic><topic>Influenza</topic><topic>Kidneys</topic><topic>Kinases</topic><topic>Mutation</topic><topic>Pathogenesis</topic><topic>Proteins</topic><topic>Rare diseases</topic><topic>Review</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Streptococcus infections</topic><topic>Transplants &amp; implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spasiano, Andrea</creatorcontrib><creatorcontrib>Palazzetti, Daniela</creatorcontrib><creatorcontrib>Dimartino, Lucrezia</creatorcontrib><creatorcontrib>Bruno, Francesca</creatorcontrib><creatorcontrib>Baccaro, Rocco</creatorcontrib><creatorcontrib>Pesce, Francesco</creatorcontrib><creatorcontrib>Grandaliano, Giuseppe</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spasiano, Andrea</au><au>Palazzetti, Daniela</au><au>Dimartino, Lucrezia</au><au>Bruno, Francesca</au><au>Baccaro, Rocco</au><au>Pesce, Francesco</au><au>Grandaliano, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?</atitle><jtitle>International journal of molecular sciences</jtitle><date>2023-10-01</date><risdate>2023</risdate><volume>24</volume><issue>19</issue><spage>14496</spage><pages>14496-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by a genetic dysregulation of the alternative complement pathway, characterized by thrombocytopenia, hemolytic anemia, and acute kidney injury, and included in the group of thrombotic microangiopathies. With the introduction of humanized monoclonal antibodies that inhibit C5 activation, the natural history of aHUS completely changed, with a better prognosis, a quick recovery of renal function, and a significant reduction of end-stage renal disease incidence. Nowadays, there is an increasing interest in the molecular and genetic bases of this severe disease. The aim of this narrative review is to provide readers with a practical guide about different possible involved genes, elucidating the specific role of each transcribed protein in the pathogenesis of aHUS. Moreover, we analyzed the main current evidence about the relationship among genetic mutations, outcomes, and the risk of recurrence of this manifold disease.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37833944</pmid><doi>10.3390/ijms241914496</doi><orcidid>https://orcid.org/0000-0002-6044-7256</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2023-10, Vol.24 (19), p.14496
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10572301
source Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database
subjects Antibodies
Chromosomes
Genes
Glycoproteins
Hypertension
Immune system
Influenza
Kidneys
Kinases
Mutation
Pathogenesis
Proteins
Rare diseases
Review
Severe acute respiratory syndrome coronavirus 2
Streptococcus infections
Transplants & implants
title Underlying Genetics of aHUS: Which Connection with Outcome and Treatment Discontinuation?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T20%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Underlying%20Genetics%20of%20aHUS:%20Which%20Connection%20with%20Outcome%20and%20Treatment%20Discontinuation?&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Spasiano,%20Andrea&rft.date=2023-10-01&rft.volume=24&rft.issue=19&rft.spage=14496&rft.pages=14496-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms241914496&rft_dat=%3Cproquest_pubme%3E2876750436%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-12bdb22267a9c0eec2b600f021872bbac3ba49b2ea4b976d109ad0a2edb089e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2876750436&rft_id=info:pmid/37833944&rfr_iscdi=true